SG11201406769RA - Agents for influenza neutralization - Google Patents
Agents for influenza neutralizationInfo
- Publication number
- SG11201406769RA SG11201406769RA SG11201406769RA SG11201406769RA SG11201406769RA SG 11201406769R A SG11201406769R A SG 11201406769RA SG 11201406769R A SG11201406769R A SG 11201406769RA SG 11201406769R A SG11201406769R A SG 11201406769RA SG 11201406769R A SG11201406769R A SG 11201406769RA
- Authority
- SG
- Singapore
- Prior art keywords
- agents
- influenza neutralization
- influenza
- neutralization
- Prior art date
Links
- 206010022000 influenza Diseases 0.000 title 1
- 238000006386 neutralization reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1018—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261645453P | 2012-05-10 | 2012-05-10 | |
| PCT/US2013/031704 WO2013169377A1 (en) | 2012-05-10 | 2013-03-14 | Agents for influenza neutralization |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201406769RA true SG11201406769RA (en) | 2014-11-27 |
Family
ID=49548780
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201406769RA SG11201406769RA (en) | 2012-05-10 | 2013-03-14 | Agents for influenza neutralization |
| SG10201807059QA SG10201807059QA (en) | 2012-05-10 | 2013-03-14 | Agents for influenza neutralization |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201807059QA SG10201807059QA (en) | 2012-05-10 | 2013-03-14 | Agents for influenza neutralization |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US9683030B2 (en) |
| EP (2) | EP2846833A4 (en) |
| JP (2) | JP6431477B2 (en) |
| KR (1) | KR102122618B1 (en) |
| CN (2) | CN109265541A (en) |
| AU (2) | AU2013260123A1 (en) |
| BR (1) | BR112014027991A2 (en) |
| CA (1) | CA2871160C (en) |
| CL (1) | CL2014003052A1 (en) |
| HK (1) | HK1207970A1 (en) |
| IL (1) | IL235237A0 (en) |
| MX (1) | MX2014013678A (en) |
| SG (2) | SG11201406769RA (en) |
| WO (1) | WO2013169377A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109265541A (en) * | 2012-05-10 | 2019-01-25 | 麻省理工学院 | In influenza and medicament |
| US9969794B2 (en) | 2012-05-10 | 2018-05-15 | Visterra, Inc. | HA binding agents |
| TWI701258B (en) | 2014-12-19 | 2020-08-11 | 美商再生元醫藥公司 | Human antibodies to influenza hemagglutinin |
| AU2016214304B2 (en) | 2015-02-05 | 2021-11-11 | Janssen Vaccines & Prevention B.V. | Binding molecules directed against influenza hemagglutinin and uses thereof |
| BR112017024206A2 (en) * | 2015-05-11 | 2018-07-17 | Janssen Vaccines & Prevention Bv | influenza virus neutralizing peptidomimetic compounds |
| EP3374390A1 (en) | 2015-11-13 | 2018-09-19 | Visterra, Inc. | Compositions and methods for treating and preventing influenza |
| AU2017222564A1 (en) | 2016-02-24 | 2018-09-06 | Visterra, Inc. | Formulations of antibody molecules to influenza virus |
| KR101887876B1 (en) | 2016-08-18 | 2018-08-13 | 한국과학기술연구원 | Nucleic acid aptamer specifically binding to H5 subtype avian influenza virus and Diagnosis method of H5 subtype avian influenza virus using the same |
| EP3946613A1 (en) | 2019-03-25 | 2022-02-09 | Visterra, Inc. | Compositions and methods for treating and preventing influenza |
| KR20220113749A (en) | 2019-12-11 | 2022-08-16 | 비스테라, 인크. | Compositions and methods for treating and preventing influenza |
Family Cites Families (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL23522C (en) | 1927-03-23 | |||
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4270537A (en) | 1979-11-19 | 1981-06-02 | Romaine Richard A | Automatic hypodermic syringe |
| US4957939A (en) | 1981-07-24 | 1990-09-18 | Schering Aktiengesellschaft | Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging |
| US4472509A (en) | 1982-06-07 | 1984-09-18 | Gansow Otto A | Metal chelate conjugated monoclonal antibodies |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| US4938948A (en) | 1985-10-07 | 1990-07-03 | Cetus Corporation | Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies |
| CA1283827C (en) | 1986-12-18 | 1991-05-07 | Giorgio Cirelli | Appliance for injection of liquid formulations |
| GB8704027D0 (en) | 1987-02-20 | 1987-03-25 | Owen Mumford Ltd | Syringe needle combination |
| US4940460A (en) | 1987-06-19 | 1990-07-10 | Bioject, Inc. | Patient-fillable and non-invasive hypodermic injection device assembly |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US5750172A (en) | 1987-06-23 | 1998-05-12 | Pharming B.V. | Transgenic non human mammal milk |
| US5339163A (en) | 1988-03-16 | 1994-08-16 | Canon Kabushiki Kaisha | Automatic exposure control device using plural image plane detection areas |
| FR2638359A1 (en) | 1988-11-03 | 1990-05-04 | Tino Dalto | SYRINGE GUIDE WITH ADJUSTMENT OF DEPTH DEPTH OF NEEDLE IN SKIN |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5633076A (en) | 1989-12-01 | 1997-05-27 | Pharming Bv | Method of producing a transgenic bovine or transgenic bovine embryo |
| EP0438803B1 (en) | 1990-01-26 | 1997-03-12 | Immunomedics, Inc. | Vaccines against cancer and infectious diseases |
| JPH049249A (en) | 1990-04-27 | 1992-01-14 | Kusuda:Kk | Facing agent spraying machine |
| US5190521A (en) | 1990-08-22 | 1993-03-02 | Tecnol Medical Products, Inc. | Apparatus and method for raising a skin wheal and anesthetizing skin |
| US5527288A (en) | 1990-12-13 | 1996-06-18 | Elan Medical Technologies Limited | Intradermal drug delivery device and method for intradermal delivery of drugs |
| JPH06247995A (en) | 1991-06-24 | 1994-09-06 | Asahi Chem Ind Co Ltd | New sialyl(alpha2-6)lactotetraosylceramide |
| GB9118204D0 (en) | 1991-08-23 | 1991-10-09 | Weston Terence E | Needle-less injector |
| SE9102652D0 (en) | 1991-09-13 | 1991-09-13 | Kabi Pharmacia Ab | INJECTION NEEDLE ARRANGEMENT |
| US5328483A (en) | 1992-02-27 | 1994-07-12 | Jacoby Richard M | Intradermal injection device with medication and needle guard |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| US5569189A (en) | 1992-09-28 | 1996-10-29 | Equidyne Systems, Inc. | hypodermic jet injector |
| US5334144A (en) | 1992-10-30 | 1994-08-02 | Becton, Dickinson And Company | Single use disposable needleless injector |
| JP3801196B2 (en) | 1993-03-09 | 2006-07-26 | ジェンザイム・コーポレイション | Isolation of the target compound from milk |
| US5500161A (en) | 1993-09-21 | 1996-03-19 | Massachusetts Institute Of Technology And Virus Research Institute | Method for making hydrophobic polymeric microparticles |
| US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
| WO1995024176A1 (en) | 1994-03-07 | 1995-09-14 | Bioject, Inc. | Ampule filling device |
| US5466220A (en) | 1994-03-08 | 1995-11-14 | Bioject, Inc. | Drug vial mixing and transfer device |
| JP3584990B2 (en) * | 1994-05-09 | 2004-11-04 | タカラバイオ株式会社 | Anti-human influenza virus antibody |
| US5599302A (en) | 1995-01-09 | 1997-02-04 | Medi-Ject Corporation | Medical injection system and method, gas spring thereof and launching device using gas spring |
| US5730723A (en) | 1995-10-10 | 1998-03-24 | Visionary Medical Products Corporation, Inc. | Gas pressured needle-less injection device and method |
| US5893397A (en) | 1996-01-12 | 1999-04-13 | Bioject Inc. | Medication vial/syringe liquid-transfer apparatus |
| GB9607549D0 (en) | 1996-04-11 | 1996-06-12 | Weston Medical Ltd | Spring-powered dispensing device |
| DE19643314A1 (en) | 1996-10-21 | 1998-04-23 | Boehringer Mannheim Gmbh | Monoclonal antibodies against the epitope YPYDVPDYA, process for their preparation and use |
| US5993412A (en) | 1997-05-19 | 1999-11-30 | Bioject, Inc. | Injection apparatus |
| DE19742706B4 (en) | 1997-09-26 | 2013-07-25 | Pieris Proteolab Ag | lipocalin muteins |
| IT1298087B1 (en) | 1998-01-08 | 1999-12-20 | Fiderm S R L | DEVICE FOR CHECKING THE PENETRATION DEPTH OF A NEEDLE, IN PARTICULAR APPLICABLE TO A SYRINGE FOR INJECTIONS |
| JP4528989B2 (en) | 1999-03-31 | 2010-08-25 | 学校法人慶應義塾 | Influenza virus / hemagglutinin-binding peptide |
| DK2322631T3 (en) | 2001-04-19 | 2015-01-12 | Scripps Research Inst | Methods and compositions for the production of orthogonal tRNA-aminoacyl-tRNA syntetasepar |
| WO2003029462A1 (en) | 2001-09-27 | 2003-04-10 | Pieris Proteolab Ag | Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| US7118915B2 (en) | 2001-09-27 | 2006-10-10 | Pieris Proteolab Ag | Muteins of apolipoprotein D |
| WO2003074570A1 (en) | 2002-03-04 | 2003-09-12 | Japan Science And Technology Agency | Novel branched sialo-sugar molecules and antiviral agents using the same |
| US8420353B2 (en) | 2002-03-22 | 2013-04-16 | Aprogen, Inc. | Humanized antibody and process for preparing same |
| AU2003265523A1 (en) | 2002-08-20 | 2004-03-11 | Genitrix, Llc | Lectin compositions and methods for modulating an immune response to an antigen |
| JP4986859B2 (en) | 2004-11-11 | 2012-07-25 | アボツト・バイオロジカルズ・ベー・ブイ | Defective influenza virus particles |
| WO2006056464A2 (en) | 2004-11-26 | 2006-06-01 | Pieris Ag | Compound with affinity for the cytotoxic t lymphocyte-associated antigen (ctla-4) |
| WO2006069246A2 (en) | 2004-12-22 | 2006-06-29 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| US7959929B2 (en) | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
| US7871626B2 (en) | 2005-08-04 | 2011-01-18 | St. Jude Children's Research Hospital | Modified influenza virus for monitoring and improving vaccine efficiency |
| CN101501696A (en) | 2006-08-14 | 2009-08-05 | 麻省理工学院 | Glycan data mining system |
| US20090081193A1 (en) | 2006-08-14 | 2009-03-26 | Massachusetts Institute Of Technology | Hemagglutinin polypeptides, and reagents and methods relating thereto |
| JP2010500880A (en) | 2006-08-14 | 2010-01-14 | マサチューセッツ・インスティテュート・オブ・テクノロジー | Hemagglutinin polypeptide and reagents and methods related to hemagglutinin polypeptide |
| US20090269342A1 (en) | 2006-08-14 | 2009-10-29 | Massachusetts Institute Of Technology | Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto |
| CA2691358C (en) * | 2007-06-25 | 2017-08-22 | The Administrators Of The Tulane Educational Fund | Influenza inhibiting compositions comprising hemagglutinin 2-derived peptides and use thereof |
| FR2921928B1 (en) * | 2007-10-08 | 2011-03-04 | Sanofi Pasteur | MONOCLONAL ANTIBODIES SPECIFIC TO INFLUENZA VIRUS HEMAGGLUTININ |
| EP3524619A1 (en) * | 2007-12-06 | 2019-08-14 | Dana-Farber Cancer Institute, Inc. | Antibodies against influenza virus and methods of use thereof |
| CA2711334A1 (en) | 2008-01-03 | 2009-07-16 | Massachusetts Institute Of Technology | Hemagglutinin polypeptides, and reagents and methods relating thereto |
| AU2009211253B2 (en) | 2008-02-05 | 2014-11-06 | Bicyclerd Limited | Methods and compositions |
| ES2662519T3 (en) | 2008-07-25 | 2018-04-06 | Institute For Research In Biomedicine | Neutralizing antibodies against influenza A virus and uses of these |
| US8871207B2 (en) * | 2008-07-25 | 2014-10-28 | Humabs, LLC | Neutralizing anti-influenza A virus antibodies and uses thereof |
| EP2528615B1 (en) | 2010-01-27 | 2020-05-13 | Massachusetts Institute of Technology | Engineered polypeptide agents for targeted broad spectrum influenza neutralization |
| US9586996B2 (en) * | 2010-04-30 | 2017-03-07 | Esperance Pharmaceuticals, Inc. | Lytic-peptide-Her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of use |
| CA2813078A1 (en) * | 2010-10-04 | 2012-04-12 | Massachusetts Institute Of Technology | Hemagglutinin polypeptides, and reagents and methods relating thereto |
| CN109265541A (en) | 2012-05-10 | 2019-01-25 | 麻省理工学院 | In influenza and medicament |
| JP6247995B2 (en) | 2014-04-22 | 2017-12-13 | 東京エレクトロン株式会社 | Joining method, program, computer storage medium, joining apparatus and joining system |
-
2013
- 2013-03-14 CN CN201811019451.4A patent/CN109265541A/en active Pending
- 2013-03-14 CA CA2871160A patent/CA2871160C/en active Active
- 2013-03-14 AU AU2013260123A patent/AU2013260123A1/en not_active Abandoned
- 2013-03-14 KR KR1020147034586A patent/KR102122618B1/en active IP Right Grant
- 2013-03-14 SG SG11201406769RA patent/SG11201406769RA/en unknown
- 2013-03-14 CN CN201380024604.3A patent/CN104507500A/en active Pending
- 2013-03-14 US US13/829,675 patent/US9683030B2/en active Active
- 2013-03-14 MX MX2014013678A patent/MX2014013678A/en unknown
- 2013-03-14 BR BR112014027991A patent/BR112014027991A2/en not_active Application Discontinuation
- 2013-03-14 EP EP13787149.7A patent/EP2846833A4/en not_active Withdrawn
- 2013-03-14 SG SG10201807059QA patent/SG10201807059QA/en unknown
- 2013-03-14 JP JP2015511463A patent/JP6431477B2/en active Active
- 2013-03-14 WO PCT/US2013/031704 patent/WO2013169377A1/en active Application Filing
- 2013-03-14 EP EP18196965.0A patent/EP3492101A3/en not_active Withdrawn
-
2014
- 2014-10-21 IL IL235237A patent/IL235237A0/en active IP Right Grant
- 2014-11-10 CL CL2014003052A patent/CL2014003052A1/en unknown
-
2015
- 2015-09-02 HK HK15108594.6A patent/HK1207970A1/en unknown
-
2017
- 2017-05-15 US US15/595,407 patent/US9982037B2/en active Active
-
2018
- 2018-04-02 JP JP2018070701A patent/JP2018118991A/en active Pending
- 2018-04-06 AU AU2018202468A patent/AU2018202468B2/en active Active
- 2018-04-23 US US15/959,430 patent/US10538578B2/en active Active
-
2019
- 2019-11-06 US US16/675,826 patent/US10947300B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018202468B2 (en) | 2020-04-16 |
| KR102122618B1 (en) | 2020-06-29 |
| BR112014027991A2 (en) | 2017-07-18 |
| JP2018118991A (en) | 2018-08-02 |
| US9683030B2 (en) | 2017-06-20 |
| JP2015517492A (en) | 2015-06-22 |
| US20190062407A1 (en) | 2019-02-28 |
| CA2871160C (en) | 2023-03-14 |
| CL2014003052A1 (en) | 2015-06-26 |
| US9982037B2 (en) | 2018-05-29 |
| MX2014013678A (en) | 2015-02-04 |
| SG10201807059QA (en) | 2018-09-27 |
| KR20150008180A (en) | 2015-01-21 |
| EP2846833A4 (en) | 2016-01-06 |
| US20200123234A1 (en) | 2020-04-23 |
| EP3492101A2 (en) | 2019-06-05 |
| EP2846833A1 (en) | 2015-03-18 |
| AU2013260123A1 (en) | 2014-11-13 |
| US10538578B2 (en) | 2020-01-21 |
| CN109265541A (en) | 2019-01-25 |
| EP3492101A3 (en) | 2019-10-23 |
| US20170306003A1 (en) | 2017-10-26 |
| WO2013169377A1 (en) | 2013-11-14 |
| HK1207970A1 (en) | 2016-02-19 |
| US20130302348A1 (en) | 2013-11-14 |
| CN104507500A (en) | 2015-04-08 |
| CA2871160A1 (en) | 2013-11-14 |
| JP6431477B2 (en) | 2018-12-05 |
| AU2018202468A1 (en) | 2018-04-26 |
| IL235237A0 (en) | 2014-12-31 |
| US10947300B2 (en) | 2021-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1203963A1 (en) | Novel therapeutic agents | |
| EP2916795A4 (en) | Improved rollator | |
| GB201212513D0 (en) | Therapeutic agents | |
| EP2814472A4 (en) | Dithioamine reducing agents | |
| EP2838564A4 (en) | Highly branched alpha-d-glucans | |
| EP2832453A4 (en) | Atomizer | |
| HK1207970A1 (en) | Agents for influenza neutralization | |
| EP2823830A4 (en) | Mucosa-elevating agent | |
| EP2934132A4 (en) | Disinfectant | |
| GB201420527D0 (en) | Electrical-wire-protecting member | |
| IL235908A0 (en) | Sanitizer system | |
| HK1202859A1 (en) | Anti -malarial agents | |
| HK1202445A1 (en) | New formulation | |
| GB201217704D0 (en) | Therapeutic agents | |
| ZA201408094B (en) | Anti-malarial agents | |
| GB2518076B (en) | Electrical-wire-protecting member | |
| GB201302688D0 (en) | Detergent formulation | |
| GB201314835D0 (en) | Spraying device | |
| EP2860271A4 (en) | Neutralization method | |
| IL235539A0 (en) | Atomizer | |
| EP2928903A4 (en) | Oligonucleotide formulation | |
| EP2861060A4 (en) | Calf wet-nurse | |
| GB201217281D0 (en) | Disinfectant formulation - MS71 | |
| AU5576P (en) | Epica INTA-Peman Chloris gayana | |
| AU349942S (en) | Spray device |